AWM
TXG icon

Avior Wealth Management’s 10x Genomics TXG Stock Holding History

Avior Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-167
Closed -$2.4K – 2220
2024
Q4 		$2.4K Buy
167
+151
+944% +$2.38K ﹤0.01% 2084
2024
Q3 		$361 Hold
16
– – ﹤0.01% 2194
2024
Q2 		$311 Hold
16
– – ﹤0.01% 2155
2024
Q1 		$600 Buy
+16
New +$703 ﹤0.01% 2521

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Avior Wealth Management's TXG Position: Q1 2025 in Review

Avior Wealth Management sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 167 shares — an estimated $2.4K sold.

Avior Wealth Management first reported a position in TXG in Q1 2024 and held it in 4 quarters. The position peaked at $2.4K in Q4 2024. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • Avior Wealth Management reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
  • Avior Wealth Management sold 167 10x Genomics shares in Q1 2025, an estimated $2.4K.
  • Avior Wealth Management first reported a position in 10x Genomics in Q1 2024 and held it in 4 quarters.
  • Avior Wealth Management's 10x Genomics position peaked at $2.4K in Q4 2024.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.